Bioventus Inc

Healthcare · Medical Devices

13.50$ -0.6% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Bioventus Inc (BVS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 673 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BVS
Line item	Q1 15	Q1 16	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	–	486	–	–	–	472	509	509	479	494	643	647	655	1,226	1,197	1,209	1,398	1,373	887	837	811	811	794	792	769	728	691	707	702	684	651	673
Current Assets	–	100	–	–	–	183	65	234	193	212	271	290	246	263	245	277	271	273	309	261	249	268	266	309	299	276	249	275	281	273	250	258
Cash	–	6.2	–	–	–	65	65	126	72	87	124	136	81	44	27	41	34	30	47	29	27	37	25	32	43	42	23	33	42	51	36	29
Cash & Short-Term Investments	–	6.2	–	–	–	65	65	126	72	87	124	136	81	44	27	41	34	30	47	29	27	37	25	32	43	42	23	33	42	51	36	29
Receivables	–	51	–	–	–	85	67	67	81	88	89	102	105	125	119	143	132	136	119	120	113	123	126	137	122	127	118	132	130	128	121	138
Inventory	–	37	–	–	–	27	34	34	35	29	40	34	37	62	65	69	77	85	88	96	98	91	97	88	90	92	94	96	96	82	83	80
Property, Plant & Equipment	–	–	–	–	–	20	–	–	20	22	26	27	27	23	25	43	43	–	53	57	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	59	–	–	–	50	50	50	50	50	54	52	53	148	148	143	15	7.5	7.5	7.5	7.5	7.5	7.5	7.5	7.5	7.5	7.5	7.5	7.5	7.5	7.5	7.5
Intangible Assets	–	318	–	–	–	217	203	203	197	192	271	258	249	695	681	667	1,056	640	516	505	493	482	471	425	415	405	396	387	377	368	360	351
Total Liabilities	–	300	–	–	–	327	-146	368	334	350	423	427	424	692	675	689	1,019	960	647	604	585	590	577	603	583	542	506	505	494	455	416	396
Current Liabilities	–	87	–	–	–	89	97	97	112	123	149	158	161	181	172	199	288	304	196	179	161	175	173	231	211	210	175	186	162	160	148	152
Short-Term Debt	–	39	–	–	–	10	17	17	16	15	15	15	15	18	20	23	31	33	41	11	20	28	36	39	39	27	37	43	11	19	19	23
Accounts Payable	–	9.8	–	–	–	6.4	14	14	8.8	4.4	10	9.9	11	17	23	26	19	37	33	41	18	23	19	24	17	24	19	24	27	11	24	20
Long-Term Debt	–	–	–	–	–	–	–	–	177	173	170	166	162	340	348	351	393	385	404	375	375	367	355	345	345	308	309	298	311	279	253	230
Shareholders' Equity	–	186	–	–	–	143	146	139	143	142	142	142	153	459	450	448	343	325	189	183	178	174	171	151	149	148	148	161	166	184	189	228
Retained Earnings	–	-98	–	–	–	-142	-145	-145	-142	-145	-1.0	-5.2	-6.2	-6.6	-18	-25	-133	-165	-304	-308	-315	-322	-326	-350	-355	-355	-360	-353	-350	-335	-332	-298
Shares Outstanding	57	56	56	56	56	57	56	56	56	38	42	42	42	55	60	61	62	62	62	63	63	63	63	64	65	65	66	69	69	69	70	71

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings